Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi Xu

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
International Journal of Hematology|June 27, 2021
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remissionKangkang Lv, Chengsen Cai, Jia Chen, et al.
Haematologica|February 12, 2026
A lower-intensity, venetoclax-containing protocol is effective in adults with newly diagnosed mixed-phenotype acute leukemiaYing Zhang, Yi Fan, Mimi Xu, et al.
Experimental Hematology & Oncology|June 2, 2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicityKangkang Lv, Bo Hu, Mingzhu Xu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2025
Noninvasive diagnosis and classification of kidney transplantation rejection by <sup>18</sup>F-FAPI-04 PET/CTSulin Luo, Mimi Xu, Rongfang Shen, et al.
Frontiers in Immunology|December 17, 2020
IL-Y Aggravates Murine Chronic Graft-<i>Versus</i>-Host Disease by Enhancing T and B Cell ResponsesLi Wan, Ziqi Jin, Bo Hu, et al.
Computers in Biology and Medicine|June 24, 2025
A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic malignanciesJia Chen, Lingyi Yang, Chao Liu, et al.
Leukemia & Lymphoma|March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantationJinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Annals of Hematology|November 20, 2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter studyYuqing Tu, Lingyi Yang, Yaxin Cheng, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
International Journal of Hematology|June 27, 2021
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remissionKangkang Lv, Chengsen Cai, Jia Chen, et al.
Haematologica|February 12, 2026
A lower-intensity, venetoclax-containing protocol is effective in adults with newly diagnosed mixed-phenotype acute leukemiaYing Zhang, Yi Fan, Mimi Xu, et al.
Experimental Hematology & Oncology|June 2, 2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicityKangkang Lv, Bo Hu, Mingzhu Xu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2025
Noninvasive diagnosis and classification of kidney transplantation rejection by <sup>18</sup>F-FAPI-04 PET/CTSulin Luo, Mimi Xu, Rongfang Shen, et al.
Frontiers in Immunology|December 17, 2020
IL-Y Aggravates Murine Chronic Graft-<i>Versus</i>-Host Disease by Enhancing T and B Cell ResponsesLi Wan, Ziqi Jin, Bo Hu, et al.
Computers in Biology and Medicine|June 24, 2025
A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic malignanciesJia Chen, Lingyi Yang, Chao Liu, et al.
Leukemia & Lymphoma|March 13, 2024
Comparison of valganciclovir <i>versus</i> foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantationJinjin Zhu, Mimi Xu, Yuhua Ru, et al.
Annals of Hematology|November 20, 2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter studyYuqing Tu, Lingyi Yang, Yaxin Cheng, et al.
Pageof 7